14 November 2022 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announced that it has hired Richard Staines, the experienced, specialist pharma and biotech journalist, to join as a permanent member of its team. Staines has joined Optimum as an Account Director with immediate effect and will be advising clients across its […]
Find out what sets Ariceum Therapetutics apart within the radiopharmaceutical arena in this insightful interview with its CEO Manfred Rüdiger and Tyler Patchen of Endpoint News
Stephanie Bewick, Chief Business Officer at Destiny Pharma outlines her experiences of how a CBO maximises their company’s commercial appeal and lands deals in the biotech industry…
Destiny Pharma strengthens Executive Management Team with the appointment of Dr Yuri Martina as Chief Medical Officer Brighton, United Kingdom – 3rd May 2022 – Destiny Pharma plc (AIM:DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today announces the appointment of Dr. Yuri Martina as Chief Medical Officer (CMO). Read more
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on its brilliant events coming up in 2022.
